A study on vancomycin treatment, new data on the investigational Pfizer C diff vaccine, how individual antibiotics are ranked by risk for C difficile infection, and more.
Excluding C difficile from Gastrointestinal Pathogen Panels Reduces Unnecessary Treatment
C difficile, Antimicrobials, and the Patients Most Affected
The Latest in Clostridioides difficile Research and News
Progress in Reducing C difficile Infections Highlights Key Achievements During C diff Awareness Month
Oral Vancomycin Reduces CDI by 64% in Stem Cell Transplant Patients
Top 5 Infectious Disease News Stories Week of November 8-15